LUPINO, Elisa
 Distribuzione geografica
Continente #
NA - Nord America 2.566
EU - Europa 1.573
AS - Asia 1.333
SA - Sud America 153
AF - Africa 29
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.671
Nazione #
US - Stati Uniti d'America 2.512
SG - Singapore 553
IT - Italia 421
CN - Cina 388
DE - Germania 195
IE - Irlanda 150
SE - Svezia 148
BR - Brasile 128
AT - Austria 124
FR - Francia 123
FI - Finlandia 114
GB - Regno Unito 95
VN - Vietnam 91
IN - India 71
UA - Ucraina 69
KR - Corea 55
CA - Canada 44
JP - Giappone 31
PL - Polonia 30
HK - Hong Kong 25
BE - Belgio 22
ES - Italia 20
NL - Olanda 18
ID - Indonesia 17
IR - Iran 17
PK - Pakistan 16
AU - Australia 15
TR - Turchia 12
AR - Argentina 10
TW - Taiwan 10
UZ - Uzbekistan 10
ZA - Sudafrica 9
IQ - Iraq 8
MX - Messico 7
SN - Senegal 7
CH - Svizzera 6
MY - Malesia 6
SA - Arabia Saudita 6
BD - Bangladesh 5
BG - Bulgaria 5
HR - Croazia 5
CO - Colombia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
IL - Israele 4
RU - Federazione Russa 4
CI - Costa d'Avorio 3
CL - Cile 3
EC - Ecuador 3
RO - Romania 3
AO - Angola 2
AZ - Azerbaigian 2
DK - Danimarca 2
EU - Europa 2
GE - Georgia 2
HU - Ungheria 2
MK - Macedonia 2
MT - Malta 2
PE - Perù 2
PT - Portogallo 2
RS - Serbia 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BZ - Belize 1
CR - Costa Rica 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
KE - Kenya 1
LV - Lettonia 1
MA - Marocco 1
ME - Montenegro 1
MN - Mongolia 1
MQ - Martinica 1
NO - Norvegia 1
NP - Nepal 1
PY - Paraguay 1
TG - Togo 1
TN - Tunisia 1
Totale 5.671
Città #
Chandler 331
Singapore 257
Beijing 216
Ashburn 182
Dublin 149
Santa Clara 148
Torino 127
Vienna 117
Ann Arbor 109
Nyköping 93
Jacksonville 90
Dearborn 76
Woodbridge 71
Fairfield 67
Houston 63
Fremont 51
Medford 48
Munich 47
Villeurbanne 46
Princeton 44
Columbus 40
Wilmington 39
Seattle 36
Los Angeles 35
Turku 31
Boardman 30
Pisa 30
Redwood City 30
Cambridge 29
Turin 29
New York 26
Milan 25
Washington 24
Boston 23
Dong Ket 23
Buffalo 22
Warsaw 22
Dallas 21
Mumbai 20
Ho Chi Minh City 19
Brussels 18
Guangzhou 18
Ottawa 18
Jakarta 15
Hong Kong 14
Helsinki 13
Viterbo 13
Toronto 11
Düsseldorf 10
Nanjing 9
Shanghai 9
São Paulo 9
Taipei 9
Chicago 8
Redondo Beach 8
San Francisco 8
Frankfurt am Main 7
Hanoi 7
Hefei 7
London 7
Paris 7
Riverside 7
Birmingham 6
Detroit 6
Epsom 6
La Jolla 6
Norwalk 6
Piemonte 6
Sherwood Park 6
Zhengzhou 6
Bari 5
Dammam 5
Durban 5
Istanbul 5
Leinì 5
Mexico City 5
Naples 5
Nuremberg 5
Nürnberg 5
Otemae 5
Phoenix 5
Rome 5
Shenyang 5
Tokyo 5
Atlanta 4
Bexley 4
Edinburgh 4
Lauterbourg 4
Montreal 4
San Jose 4
Sassari 4
Sesto Fiorentino 4
Stockholm 4
Agliè 3
Amsterdam 3
Arlington 3
Baghdad 3
Basel 3
Belo Horizonte 3
Berlin 3
Totale 3.293
Nome #
PROCEEDINGS OF THE MERCK & ELSEVIER YOUNG CHEMISTSSYMPOSIUM 369
TDP-43 Redistribution Is an Early Event in Sporadic Amyotrophic Lateral Sclerosis 315
Exposure of neuroblastoma cell lines to imatinib results in the upregulation of the CDK inhibitor p27KIP1 as a consequence of c-Abl inhibition 303
Development of Potent Human Dihydroorotate Dehydrogenase Inhibitors Able to Induces Myeloid Differentiation 203
Design, synthesis, biological evaluation and X-ray structural studies of potent human dihydroorotate dehydrogenase inhibitors based on hydroxylated azole scaffolds 194
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade 161
N-Acetyl-3-aminopyrazoles block the non canonical NF-kB cascade by selectively inhibiting NIK 158
Increased cytoplasmic mislocalization of TAR DNA binding protein 43 (TDP-43) in circulating lymphomonocytes of ALS patients recapitulates the major dysfunction featuring motor neurons in the disease. 155
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 151
IκB kinase β is required for activation of NF-κB and AP-1 in CD3/CD28-stimulated primary CD4(+) T cells. 150
Targeting Myeloid Differentiation Using Potent 2-Hydroxypyrazolo[1,5- a]pyridine Scaffold-Based Human Dihydroorotate Dehydrogenase Inhibitors 148
The expression pattern of TAR DNA-binding protein 43 (TDP-43) in peripheral blood mononuclear cells (PBMC) in individuals affected by amyotrophific lateral sclerosis (ALS) and their healthy relatives 144
Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations 143
TOWARD A BIOISOSTERIC ALKAEST – APPLICATION TO THE BIOISOSTERIC MODULATION OF IMD-0354 140
Alterations of myelin-specific proteins and sphingolipids characterize the brains of acid sphingomyelinase-deficient mice, an animal model of niemannpick disease type A 136
Deregulated Sphingolipid Metabolism and Membrane Organization in Neurodegenerative Disorders 132
Nitrooxyacyl Derivatives of Salicylic Acid: Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-1 131
Targeting the human Dihydroorotate Dehydrogenase (hDHODH) by a Scaffold Hopping Bioisosteric approach using Hydroxylated Pentatomic Heterocycles 130
An approach to the timing of altered localization of TDP-43 in ALS motor neurons during disease progression 127
In vitro myeloid differentiation using a new generation of potent human dihydroorotate dehydrogenase inhibitors 127
Towards a Bioisosteric Alkaest: application to the bioisosteric modulation of IMD-0354 126
Targeting the human Dihydroorotate Dehydrogenase (hDHODH) by combination of in-silico ligand/structural pharmacophore models and scaffold hopping bioisosteric approaches 126
Discovery of new NIK inhibitors by Structure-Based Drug Design 123
Targeting the human Dihydroorotate Dehydrogenase (hDHODH) by a Scaffold Hopping Bioisosteric approach using Hydroxylated Pentaatomic Heterocycles 122
Dysfunctions in N_CAM and unexpected accumulation of PSA_NCAM in brain of Autosomal dominant adult onset leukodystrophy (ADLD) 120
TDP-43 redistribution is an early event in sporadic amyotrophic lateral sclerosis 114
Altered sphingolipid metabolism in acidic sphingomyelinase knocout mice, an animal model for Niemann-Pick disease type A 113
Emerging therapies for acute myeloid leukaemia using hDHODH inhibitors 113
Targeting myeloid differentiation using potent human dihydroorotate dehydrogenase (hDHODH) inhibitors 108
Expression pattern of the 20S proteasome subunits following T cell activation 107
In CD28-costimulated human naïve CD4(+) T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms 104
Alterations of protein and lipid patterns in brain white matter of ASMKO mice, the animal model of Niemann-Pick disease type A 103
Biomarker for Frontotemporal Lobar Degeneration (FTLD) with TDP-43 Pathology: the Circulating Lymphocytes 102
Pregnancy induces molecular alterations reflecting impaired insulin control over glucose oxidative pathways that only in women with a family history for type 2 diabetes last beyond pregnancy 101
The molecular basis of the hypomyelination characterizing the brains of sphingomyelinase-deficient mice, an animal model of Niemann-Pick disease type A 97
Novel dysfunctions at the origin of hypomyelination, a feature of Niemann Pick type A 96
Reduced cellular Ca(2+) availability enhances TDP-43 cleavage by apoptotic caspases. 90
N-CAM Dysfunction and Unexpected Accumulation of PSA-NCAM in Brain of Adult-Onset Autosomal-Dominant Leukodystrophy. 77
Reduced expression of proteins characterizing myelin sheaths in brain of acid sphingomyelinase-deficinet mice, the animal model of Niemann-Pick disease type A 75
New human dihydroorotate dehydrogenase inhibitors able to restore myeloid differentiation in AML 74
Targeting the human Dihydroorotate Dehydrogenase (hDHODH) by a Scaffold Hopping Bioisosteric approach using Hydroxylated Pentatomic Heterocycles 73
null 65
Toward a Bioisosteric Alkahest: Targeting the human Dihydroorotate Dehydrogenase (hDHODH) by a Scaffold Hopping Bioisosteric approach using Hydroxylated Pentatomic Heterocycles 56
Totale 5.802
Categoria #
all - tutte 17.197
article - articoli 0
book - libri 0
conference - conferenze 10.086
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.283


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 39 16 37 20 58 32 25 46
2021/2022577 20 13 33 35 17 41 30 19 13 59 198 99
2022/2023869 90 114 19 107 61 218 52 54 72 21 40 21
2023/2024362 53 81 38 14 12 43 5 13 1 31 16 55
2024/20251.124 23 95 41 141 231 52 19 22 206 50 108 136
2025/2026707 268 57 95 187 100 0 0 0 0 0 0 0
Totale 5.802